Cyril Allouche Email

Financial Advisor . Emmecell

Current Roles

Employees:
11
Revenue:
$1.7M
About
Emmetrope Ophthalmics LLC, (aka “Emmecell”) is a privately-held, clinical stage biotechnology company developing cell-based therapies. Emmecell’s platform technology leverages magnetic nanoparticles to effectively localize and integrate cell therapies to the appropriate target tissue. Our lead product EO2002 is a cell therapy for treatment for corneal edema, the most common indication for corneal transplantation. Cell Manufacturing and Production LLC (CellMP) was founded in 2018 and is a subsidiary of Emmecell providing GMP manufacturing services in Menlo Park, CA.
Emmecell Address
3475 Edison Way
Menlo Park, CA
Emmecell Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.